Sipai Health 00314Prospectus Information

Prospectus & Stock Connect
Data layers Raw facts Calculated Model prediction AI interpretation
Company Overview
Stock NameSipai Health
Stock Code00314
Company Full NameTo be extracted
Industry醫療保健
Principal Activities主要在中國從事特藥藥房業務、醫生研究協助業務及健康保險服務業務。
Listing Date2022-12-23
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國廣東省廣州市廣州國際生物島螺旋大道51號官洲生命科學創新中心A塔26樓11–13室
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttps://www.medbankshealthtech.com/
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo data
Offering Information
Offering Mechanism To be extracted
Offer PriceHK$ 18.60 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)—
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 18,451,200
Stock Connect Inclusion
HK Market Cap ---
26Q2 Regular Review
Inclusion Pathway None
Est. Threshold ---
Analysis Result 无法确定入通路径
Valuation & Financials
Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day Performance
First Day CloseHK$ 25.0
First Day OpenHK$ 23.7
First Day Change34.41%
First Day Volume2174600.0
First Day Turnover52611300.0
Use of Proceeds
Use of Proceeds1、約87%或約104.8百萬港元預計將用于業務擴張; 2、約13%或約15.6百萬港元預期將用于技術研發及提升技術基礎設施。
Underwriting Syndicate
Joint Sponsors (2)
Morgan Stanley Asia Limited CE AAD291 HAITONG INTERNATIONAL CAPITAL LIMITED CE ADQ859
Overall Coordinators (2)
Morgan Stanley Asia Limited CE AAD291 HAITONG INTERNATIONAL SECURITIES COMPANY LIMITED CE AAF806
Joint Bookrunners (2)
Morgan Stanley Asia Limited CE AAD291 HAITONG INTERNATIONAL SECURITIES COMPANY LIMITED CE AAF806
Joint Lead Managers (5)
Morgan Stanley Asia Limited CE AAD291 HAITONG INTERNATIONAL SECURITIES COMPANY LIMITED CE AAF806 Futu Securities International (Hong Kong) Limited CE AZT137 迈时资本有限公司 CE BNO600 I WIN SECURITIES LIMITED CE BJB315
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
Chairman馬旭廣
Company Secretary任娜
No director data available.
Major Shareholders
Major Shareholders & Holdings騰訊控股有限公司(27.41%);FMR LLC(9.09%);馬旭廣(7.47%);Ching Hsin Chang Jimmy(6.96%),方舟信托(香港)有限公司(5.30%);李繼(5.24%)
// About this page //

This page shows Sipai Health (00314) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements.

Disclaimer

Site Nature: This website (cibo.hk) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect